A 25-year-old Japanese woman with a large abdominal tumor (10 cm in diameter) and high level of serum alpha-fetoprotein (AFP, 1,222.4 ng/mL) was introduced and admitted to our hospital in January 2011. Preoperative imaging modalities could not identify the tumor origin. There was no chronic hepatic viral disease, however, the elevated level of fucosylated AFP (87.8%) and connection with the left hepatic lobe led us to diagnose the tumor as a hepatocellular carcinoma. Surgical resection was performed in February. Histological findings revealed a pancreatic acinar cell carcinoma (ACC). Herein, we provide details of this difficulty to diagnose a case of ACC.
Introduction
Serum alpha-fetoprotein (AFP) and fucosylated AFP (AFP-L3) are known as tumor markers of hepatocellular carcinoma (HCC) (1, 2) . Only a small number of pancreatic acinar cell carcinoma (ACC) cases with elevation of AFP have been reported in literature (Table 1 ) (3-28). Moreover, only a small number of reports have documented lectin fractionation of AFP in ACC (8, 17, 21) . We present a case of large pancreatic ACC accompanied by high levels of AFP and AFP-L3, which was difficult to diagnose prior to surgery.
Case Report
A 25-year-old Japanese woman with a large abdominal tumor and high level of serum AFP (1, 222 .4 ng/mL) was introduced to our hospital in January 2011 for further examinations. When she bruised her abdomen in skiing and abdominal computed tomography (CT) was performed for the pain. A large abdominal tumor was found incidentally. Dynamic CT revealed a huge hypervascular abdominal tumor with central necrosis without other tumors or metastasis (Fig. 1 ). Abdominal ultrasonography (US) showed a hypoechoic tumor 10 cm in diameter with connection to the left hepatic lobe, stomach, and pancreas (Fig. 2a) . We considered that the mass originated from the left hepatic lobe. Laboratory data on admission are presented in Table 2 .
The serum levels of AFP and AFP-L3 were 2,550.8 ng/ mL and 87.8%, respectively. Neither markers of viral hepatitis nor elevated serum levels of carcinoembryonic antigen (CEA, 2.0 ng/mL) or carbohydrate antigen 19-9 (CA19-9, 17.7 U/mL), DUPAN-2 (66 U/mL), or Span-1 (10.8 U/mL) were detected (Table 2) . 18 F-fluorodeoxy glucose positron emission tomography (FDG-PET)/CT showed a high uptake of 18 F-fluorodeoxy glucose (max-standardized uptake value, 8.4) in the tumor and no metastasis (Fig. 2b) . A contrastenhanced US (CEUS) examination with Sonazoid (Perflubutane; Daiichi Sankyo, Tokyo, Japan) showed a suspected necrotic area in the center of the tumor and the description was non-vascular. Furthermore, B-mode US did not detect another hepatic tumor other than the main large abdominal mass. In the Kupffer phase of CEUS, a small defect (0.9 cm in diameter) was detected in the 5th segment of the liver (Fig. 2c) , which was enhanced by re-injection of Sonazoid (Fig. 2d) . Though, pancreas became atrophic and the main pancreatic duct (MPD) appeared to be suspended due to oppression of the tumor, the dilatations of MPD and common bile duct were not revealed by magnetic resonance cholangiopancreatography (MRCP). However, occlusion of the splenic vein was suspected by late phase of dynamic CT. Angiography showed the occlusion of the splenic vein by compression with the tumor and formation of collateral vessels. In spite of the compression with the tumor, the portal vein was intact by portography, and gastroduodenal artery was found to be the main feeder of the tumor (Fig. 3) . We made a diagnosis of HCC and intrahepatic metastasis of HCC based on serological examination results (AFP, AFP-L3), as well as hypervascular findings in dynamic CT and CEUS images. Surgical resection of the main tumor and small lesion in the 5th segment of the liver was performed in February 2011 (pancreaticoduodenectomy-II A-2, Hr0). The main tumor was located in the pancreas head. Portal vein and common bile duct were oppressed by the tumor. Adhesion between the tumor and splenic vein was observed in macroscopic finding (Fig. 4a-c) . The atypical cells with eosinophilic cytoplasm formed microglandular structures as seen by Hematoxylin and Eosin (HE) staining. The large tumor and hepatic tumor were diagnosed as a pancreatic acinar cell carcinoma. Chromogranin was negative by immune staining (Fig. 4f-h ). Pathological examinations of the tumors revealed ACC and hepatic metastasis (medullary type, INF α, ly1, v1, ne0, mpd-, pCH-, pDU, pS-, pRP-, pPVsp+, pA-, pPLX, pOO-, n(-0/4). pT4N0M1(HEP), pStage IV) (29) . Tumor invasion to the splenic vein was proven histologically. Immunostaining for AFP was positive (Fig. 4i) . Multiple hepatic metastases and peritoneal dissemination were diagnosed 8 months after resection and she was treated by chemotherapy with Gemcitabine (Gemzar ). Two months after diagnosis of recurrence, she was died.
Discussion
Pre-operative diagnosis is difficult in many cases of ACC (30) . One case was diagnosed as rupture of HCC (17) . In the present case, both AFP and AFP-L3, which is known as a specific tumor marker for HCC (1, 2), were elevated, and elevation of the latter made it difficult to diagnose the huge tumor originating from the pancreas before the operation. Although the positivity rate for AFP is reported to be under 10% in cases of fibrolamellar carcinoma (31), it must be considered in the differential diagnosis (32) along with ectopic HCC (33) in cases with an abdominal tumor in another organ other than the liver, as in the present case. In 4 cases of past reports, AFP-L3 was examined, and 3 of them showed elevation of AFP-L3. Elevation of AFP-L3 in AFPproducing ACC might not be rare. There were only 4 cases (14.3%), which were diagnosed as ACC pre-operative or pre-autopsy, in past reports (Table 1 ).
An ACC is a rare tumor that comprises approximately 1% of exocrine pancreatic tumors (34, 35) . Klimstra et al. reported no significant gender differences for affected patients and a poor prognosis, and also estimated that AFP producing ACC tumors were found in 6% of these cases, with pancreatic ACC found in the head of the pancreas in slightly 17.7 U/mL DUPAN-2 66 U/mL Span-1 10.8 U/mL S-IL-2 R 238 U/mL
HbA1c, hemoglobin A1c; FBG, fasting blood glucose; ESR, erythrocyte sedimentation rate; PT, prothrombin time; TP, total protein; Alb, albumin; T-Bil, total bilirubin; AST, aspartate aminotransferase; ALT, alanine aminotransferase; ALP, alkaline Phosphatase; ChE, cholinesterase; TTT, thymol turbidity test; ZTT, zinc turbidity test; Amy, amylase; BUN, blood urea nitrogen; Cre, creatinine; Na, sodium; K, potassium; Cl, chlorine; AFP, alpha-fetoprotein; AFP-L3, fucocylated AFP; PIVKA-II, protein induced by vitamin K absence-II; CEA, carcinoembryonic antigen; CA19-9, carbohydrate antigen 19-9; S-IL-2 R, soluble interleukin-2 receptor ; HBsAg, hepatitis B surface antigen; HBcAb, hepatitis B core antibody; anti-HCV, hepatitis C virus antibody; ANA, antinuclear antibody ; AMA (M2), antimitochondrial antibody (M2); IgG, immunoglobulin G more than half (56%) (36) . On the other hand, the 5-year survival rate after resection was described to be favorable (43.9%) in the resectable cases (30).
AFP is a tumor marker for HCC. Ishizaki et al. reported that cases of pancreatic ACC with elevated serum AFP are very rare (11), whereas the frequency of pancreatic neo- plasms in patients with elevated serum AFP levels is higher in previous reports (37) . Other studies also noted that ACCs comprised 27% of pancreatic neoplasms in cases with elevated serum AFP levels (38) . The mechanism of production of AFP without HCC has not been elucidated, though production of AFP by hepatoid differentiation of cancer cells (39) (40) (41) and production of AFP by entero-blastic differentiation (42) have been proposed. The reasons for the elevation of AFP-L3 could not be clearly elucidated. It is important to bear in mind that elevation of AFP-L3 could be observed in AFP producing ACC.
Metastasis was not detected by FDG-PET/CT in the present case. Although it is a powerful modality for screening of metastasis, FDG-PET/CT has a limitation for the detection of small metastatic hepatic tumors (<1 cm) in the liver because of resolution limits (43) . CEUS with Sonazoid has been reported as a useful modality for the detection for hepatic malignant tumors (44) and screening of hepatic metastasis (43) . Using CEUS with Sonazoid, a small tumor was detected as a defect in the 5th segment of the liver in the Kupffer phase in the present case and enhanced uniformly by re-injection (45) . We diagnosed the small tumor as intrahepatic metastasis of HCC prior to resection. Although, distal MPD was revealed without dilatation by MRCP, multiplanar reconstruction images of enhanced CT (MPR-CT) provided more information than magnetic resonance imaging (MRI) and MRCP regarding portal and splenic veins in preoperative studies of the present case. Though, the enhancement pattern of the tumor was similar to HCC, and serum levels of AFP and AFP-L3 were elevated, we should suspect that the origin of the tumor was the pancreas head, because displacement of the bilateral lobes of the liver was observed and the main feeder of the tumor was the gastroduodenal artery. Further examination endoscopic ultrasonography (EUS) should be considered to perform in order to discriminate whether the origin of the tumor was the pancreas or not. Recently, EUS fine needle aspiration (EUS-FNA) has been reported to be an effective modality for the diagnosis of AFP producing ACC (21, 25) . The elevation of the levels of AFP and AFP-L3 mislead us in the present case. And we suspected an ectopic or fibrolamellar HCC at first, and did not plan to perform EUS-FNA. Following surgical resection, HE staining showed that the atypical cells with eosinophilic cytoplasm formed microglandular structures. It is difficult to obtain stability of immune staining of trypsin, chymotrypsin, lipase, and/or elastase. Though, these immune stainings of trypsin and chymotrypsin were negative in the present pathological findings, pancreatic ductal cancer and neuroen- docrine tumor were denied, and histological findings led to a final diagnosis of AFP producing ACC.
In the past reports, 1-and 3-year survival rates of the cases that could be treated with resection were approximately 70 and 50%, respectively. However, the prognoses of the cases which were not indicated for surgical resection and treated only with chemotherapy were very poor. One-year survival rate of such cases was approximately 20%. Establishment of effective methods for preoperative diagnosis and a therapeutic strategy for ACC is needed. No therapeutic strategy except for resection has been established. Accumulation of additional cases is needed to establish strategies for the diagnosis and therapy for ACC, especially those producing AFP.
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